Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mantle Cell Lymphoma; Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnded earlyNCT03272633
What this trial is testing

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia in RemissionHematopoietic Cell Transplantation Recipient+16 more
Rutgers, The State University of New Jersey 2
Large-scale testing (Phase 3)Active Not RecruitingNCT03267433
What this trial is testing

Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

Who this might be right for
Mantle Cell Lymphoma
ECOG-ACRIN Cancer Research Group 689
Testing effectiveness (Phase 2)Study completedNCT01739309
What this trial is testing

Study of LY2835219 for Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Eli Lilly and Company 28
Large-scale testing (Phase 3)Study completedNCT01646021
What this trial is testing

Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy

Who this might be right for
Mantle Cell Lymphoma
Janssen Research & Development, LLC 280
Early research (Phase 1)Looking for participantsNCT06191887
What this trial is testing

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

Who this might be right for
B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+12 more
Mayo Clinic 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748364
What this trial is testing

Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics

Who this might be right for
Relapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Mantle Cell Lymphoma
Joshua Brody 16
Testing effectiveness (Phase 2)Looking for participantsNCT05529069
What this trial is testing

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

Who this might be right for
Mantle Cell LymphomaNon Hodgkin LymphomaHematologic Malignancy
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Not applicableUnknownNCT01864889
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05214183
What this trial is testing

Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma

Who this might be right for
MCLMantle Cell Lymphoma
Nordic Lymphoma Group 81
Testing effectiveness (Phase 2)Looking for participantsNCT05643742
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Who this might be right for
B-cell LymphomaNon-Hodgkin LymphomaB-cell Malignancy+5 more
CRISPR Therapeutics AG 120
Early research (Phase 1)Study completedNCT02381080
What this trial is testing

Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLC 26
Testing effectiveness (Phase 2)Study completedNCT00002879
What this trial is testing

Cladribine in Patients With Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 51
Early research (Phase 1)Study completedNCT00004260
What this trial is testing

Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Mayo Clinic
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00509379
What this trial is testing

Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma

Who this might be right for
LymphomaNon-Hodgkin Lymphoma
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie 48
Not applicableWithdrawnNCT00499668
What this trial is testing

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+5 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00281879
What this trial is testing

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 200
Testing effectiveness (Phase 2)Study completedNCT00004197
What this trial is testing

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT03567876
What this trial is testing

Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL

Who this might be right for
Lymphoma, Mantle-Cell
Fondazione Italiana Linfomi - ETS 141
Next Page